Shepherd Kaplan Krochuk, LLC Neurocrine Biosciences Inc Transaction History

Shepherd Kaplan Krochuk, LLC

  • $116 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 11, 2018
SELL
$75.88 - $92.43 $310,652 - $378,408
-4,094 Closed
0 $0
Q4 2017

Feb 13, 2018
SELL
$58.53 - $77.59 $238,509 - $316,179
-4,075 Reduced 49.88%
4,094 $318,000
Q3 2017

Nov 14, 2017
BUY
$47.97 - $61.28 $391,866 - $500,596
8,169
8,169 $501,000

Others Institutions Holding NBIX

# of Institutions
652
Shares Held
95.8M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.2B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Shepherd Kaplan Krochuk, LLC Portfolio

Follow Shepherd Kaplan Krochuk, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shepherd Kaplan Krochuk, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shepherd Kaplan Krochuk, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email